Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)

Market Cap	3.26B -30.8%
Revenue (ttm)	485.94M +42.7%
Net Income	-8.91M
EPS	-0.02
Shares Out	544.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,563,810
Open	5.97
Previous Close	6.15
Day's Range	5.95 - 6.19
52-Week Range	5.19 - 10.41
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHE:300289

Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People’s Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. It also provides biochemical reagents for liver function...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 405
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300289

Financial Performance

In 2025, SHE:300289's revenue was 326.31 million, a decrease of -11.86% compared to the previous year's 370.23 million. Losses were -22.98 million, -69.40% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error